UiPath shares surge 25.4% after-hours on Q3 earnings beat, AI automation demand, and upbeat guidance.

UiPath surged 25.4% in after-hours trading following a Q3 earnings report that significantly exceeded estimates, with revenue up 16% to $411.1 million and adjusted EPS at $0.16 (beating forecasts of $0.15). The company’s annualized recurring revenue rose 11% to $1.782 billion, and it provided optimistic guidance for Q4 and 2026. CEO Daniel Dines highlighted momentum in AI automation adoption, while analysts revised estimates upward, citing improved enterprise traction and AI product execution. Additionally, UiPath’s partnership with Veeva to streamline AI-driven validation workflows in life sciences underscored its expanding AI automation capabilities, further bolstering investor confidence. The stock’s sharp rise aligned with strong post-earnings sentiment, strategic AI partnerships, and revised analyst expectations.